| Literature DB >> 35845631 |
Chen Chen1,2, Bo Wang1,2, Jingjing Li3, Feng Xiong1, Guoying Zhou1.
Abstract
Anisodus tanguticus (Maxim.) Pascher, has been used for the treatment of septic shock, analgesia, motion sickness, and anesthesia in traditional Tibetan medicine for 2,000 years. However, the chemical metabolites and geographical traceability and their network pharmacology are still unknown. A total of 71 samples of A. tanguticus were analyzed by Ultra-Performance Liquid Chromatography Q-Exactive Mass Spectrometer in combination with chemometrics developed for the discrimination of A. tanguticus from different geographical origins. Then, network pharmacology analysis was used to integrate the information of the differential metabolite network to explore the mechanism of pharmacological activity. In this study, 29 metabolites were identified, including tropane alkaloids, hydroxycinnamic acid amides and coumarins. Principal component analysis (PCA) explained 49.5% of the total variance, and orthogonal partial least-squares discriminant analysis (OPLS-DA) showed good discrimination (R2Y = 0.921 and Q2 = 0.839) for A. tanguticus samples. Nine differential metabolites accountable for such variations were identified through variable importance in the projection (VIP). Through network pharmacology, 19 components and 20 pathways were constructed and predicted for the pharmacological activity of A. tanguticus. These results confirmed that this method is accurate and effective for the geographic classification of A. tanguticus, and the integrated strategy of metabolomics and network pharmacology can explain well the "multicomponent--multitarget" mechanism of A. tanguticus.Entities:
Keywords: A. tanguticus; chemometrics analysis; geographical origins; metabolites; network pharmacology
Year: 2022 PMID: 35845631 PMCID: PMC9277180 DOI: 10.3389/fpls.2022.927336
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 6.627
Figure 1Geographical distribution of the regions of A. tanguticus.
Figure 2The base peak ions (BPI) chromatogram of A. tanguticus by UPLC–Q–Exactive–MS in positive ion mode.
Mass spectrometric data of A. tanguticus.
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|
|
| |||||||
| 1 | 4.23 | 268.1039 | C10H13N5O4 | 136, 119 | Adenosine | −0.48 | Standard |
| 2 | 6.41 | 322.2119 | C17H27N3O3 | 251, 224, 186, 163, 135 | −1.92 | ||
| 3 | 7.22 | 320.1494 | C17H21NO5 | 156, 138, 119, 98 | Anisodine | 0.47 | Standard |
| 4 | 10.51 | 306.1692 | C17H23NO4 | 281, 224, 193, 169, 147 | Convolamine | 1.82 | |
| 5 | 11.87 | 322.1648 | C17H27N3O3 | 193, 156, 113 | −0.29 | ||
| 6 | 14.11 | 306.1705 | C17H23NO4 | 288, 140, 169 | Physochlain | 1.68 | |
| 7 | 15.26 | 304.1541 | C17H21NO4 | 103, 93 | Scopolamine | −0.77 | Standard |
| 8 | 16.38 | 355.1024 | C16H18O9 | 193, 178 | scopolin | 0.12 | Standard |
| 9 | 16.65 | 487.1439 | C21H26O13 | 341, 193, 179 | fabiatrin | 1.28 | Standard |
| 10 | 17.61 | 306.1704 | C17H23NO4 | 193, 140, 122, 91 | anisodamine | 1.35 | Standard |
| 11 | 22.32 | 474.2606 | C25H35N3O6 | 222, 236, 165, 123 | −1.26 | (Yang et al., | |
| 12 | 23.95 | 276.1597 | C16H21NO3 | 128, 121, 110, 93 | Noratropine | 1.01 | (Chen et al., |
| 13 | 24.32 | 472.2453 | C25H33N3O6 | 293, 220, 165, 163 | −0.53 | (Yang et al., | |
| 14 | 24.49 | 290.1740 | C17H23N3O3 | 124, 93 | Atropine | 0.94 | Standard |
| 15 | 25.40 | 193.0497 | C10H8O4 | 133, 122, 94, 77 | Scopoletin | 0.85 | Standard |
| 16 | 25.78 | 470.2293 | C25H31N3O6 | 380, 290, 220, 141 | 0.49 | (Yang et al., | |
| 17 | 26.15 | 488.2748 | C26H37N3O6 | 310, 236, 179, 141 | 1.29 | ||
| 18 | 28.12 | 502.2909 | C27H39N3O6 | 249, 236, 177, 137 | 0.51 | ||
| 19 | 28.67 | 500.2756 | C27H37N3O6 | 234, 177, 145 | 0.17 | ||
| 20 | 31.89 | 314.1388 | C18H19NO4 | 177, 121 | Feruloyltyramine | 0.37 | |
| 21 | 32.46 | 344.1490 | C19H21NO5 | 177, 145 | N-trans-feruloyl-4'-O-methyldopamine | −0.71 | |
| 22 | 37.18 | 302.3053 | C18H39NO2 | 121 | Sphinganine | −0.19 | |
| 23 | 37.75 | 346.3313 | C20H40O3 | 258, 180, 121 | Hydroxyicosanoic acid | −0.78 | |
| 24 | 39.18 | 330.3370 | C20H40O2 | 121 | Phytanic acid | 1.04 | |
| 25 | 40.97 | 274.2443 | C16H32O2 | 256, 106 | Butyl laurate | 2.99 | |
| 26 | 41.28 | 318.3004 | C18H36O3 | 290, 274, 256, 242 | Hydroxyoctadecanoic acid | 0.41 | |
| 27 | 41.69 | 219.1744 | C15H22O | 201, 184 | Turmerone | 0.27 | |
| 28 | 42.09 | 412.2096 | C17H34NO8P | 184 | 1,2-Dihexanoyl-sn-glycero-3-phosphoethanolamine | 1.04 | |
| 29 | 43.52 | 496.3395 | C24H50NO7P | 301 | 1-nonadecanoyl-glycero-3-phosphoethanolamine | 0.09 |
Figure 3PCA results of A. tanguticus. Score plot with the first two principal components of A. tanguticus (A), Loading plot of PC1 and PC2 of A. tanguticus (B).
Figure 4OPLS-DA results of A. tanguticus. Score plot from OPLS-DA (A), Loading plot from OPLS-DA (B).
Figure 5Correlation analysis results of metabolites in A. tanguticus and environmental factors [altitude (ALT), longitude (LON), latitude (LAT), annual mean temperature (AMT) and annual average precipitation (AAP)].
Figure 6The results of bioinformatics analysis. GO enrichment analysis of targets (A), KEGG pathway enrichment analysis (B).
Figure 7Network pharmacology analysis of difference metabolites in A. tanguticus. (Blue is the compound, yellow is the target of the compound, green is the top 20 prominent pathways).